Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozden Altundag

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|August 31, 2011
Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experienceFatih Kose, Ayberk Besen, Taner Sumbul, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 18, 2025
Posttransplant Malignancies in Adult Transplant PatientsMehmet Nezir Ramazanoglu, Aydan Farzaliyeva, Emre Karakaya, et al.
Medical Oncology (Northwood, London, England)|December 17, 2013
The relationship between thyroid volume and malignant thyroid diseaseAyse Ocak Duran, Cuneyd Anil, Alptekin Gursoy, et al.
In Vivo (Athens, Greece)|January 2, 2026
Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant TherapyEce Duygu Gulsen, Rashad Ismayilov, Aydan Farzaliyeva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapyOzden Altundag, David J Stewart, Frank V Fossella, et al.
Head & Neck|October 30, 2004
Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patientsOzden Altundag, Ibrahim Gullu, Kadri Altundag, et al.
Bioengineering (Basel, Switzerland)|February 26, 2025
Automated Extraction of Key Entities from Non-English Mammography Reports Using Named Entity Recognition with Prompt EngineeringZafer Akcali, Hazal Selvi Cubuk, Arzu Oguz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 18, 2014
Good outcomes of patients with stage IB endometrial cancer with surgery aloneSamed Rahatli, Omer Dizdar, Nadire Kucukoztas, et al.
Japanese Journal of Radiology|October 15, 2025
Artificial intelligence for immunotherapy response assessment in lung cancer using PET/CT reportsRashad Ismayilov, Ozden Altundag, Esra Arzu Gencoglu, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 30, 2020
Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical stagingMelis Gultekin, Ozan Cem Guler, Sezin Yuce Sari, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Asian Pacific Journal of Cancer Prevention : APJCP|August 31, 2011
Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experienceFatih Kose, Ayberk Besen, Taner Sumbul, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 18, 2025
Posttransplant Malignancies in Adult Transplant PatientsMehmet Nezir Ramazanoglu, Aydan Farzaliyeva, Emre Karakaya, et al.
Medical Oncology (Northwood, London, England)|December 17, 2013
The relationship between thyroid volume and malignant thyroid diseaseAyse Ocak Duran, Cuneyd Anil, Alptekin Gursoy, et al.
In Vivo (Athens, Greece)|January 2, 2026
Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant TherapyEce Duygu Gulsen, Rashad Ismayilov, Aydan Farzaliyeva, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Many patients 80 years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapyOzden Altundag, David J Stewart, Frank V Fossella, et al.
Head & Neck|October 30, 2004
Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patientsOzden Altundag, Ibrahim Gullu, Kadri Altundag, et al.
Bioengineering (Basel, Switzerland)|February 26, 2025
Automated Extraction of Key Entities from Non-English Mammography Reports Using Named Entity Recognition with Prompt EngineeringZafer Akcali, Hazal Selvi Cubuk, Arzu Oguz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 18, 2014
Good outcomes of patients with stage IB endometrial cancer with surgery aloneSamed Rahatli, Omer Dizdar, Nadire Kucukoztas, et al.
Japanese Journal of Radiology|October 15, 2025
Artificial intelligence for immunotherapy response assessment in lung cancer using PET/CT reportsRashad Ismayilov, Ozden Altundag, Esra Arzu Gencoglu, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|April 30, 2020
Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical stagingMelis Gultekin, Ozan Cem Guler, Sezin Yuce Sari, et al.
Pageof 5